Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Posted inCOVID-19, Infections, Regulatory
Paxlovid for COVID-19 Treatment. All Details
Paxlovid: treatment efficacy, “Paxlovid mouth”, COVID-19 rebound, management of Omicron variant, treatment resistance, generics, mechanism of action, price.
Posted inNeuroscience, New Drugs, Regulatory
Auvelity: New Antidepressant for Most Severe Depression
Dextromethorphan and bupropion: A powerful drug combination that will help with depression that cannot be treated with standard antidepressants.
Posted inCOVID-19, Infections, New Drugs, Regulatory
First Omicron Vaccine Appears
Spikevax bivalent Original / Omicron (elasomeran + imelasomeran; mRNA-1273.214) by Moderna is the world’s first vaccine to protect against the Omicron variant of the SARS-CoV-2 coronavirus.
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory
Alopecia Areata Treatment: What Future Holds
What new drugs for hair loss are being developed by the pharmaceutical industry?
Posted inAutoimmune Diseases, New Drugs, Regulatory
Zoryve: New Effective Cream for Psoriasis
Roflumilast will cure plaque psoriasis in half of patients.
